IGF1 and Hyperinsulinemia: Experimental and epidemiological evidence indicate that hyperinsulinemia and elevated levels of insulin-like growth factor- 1 (IGF-1) may promote colorectal tumorigenesis by stimulating mitogenesis and inhibiting apoptosis24–30.